Tags |
|
|
Links |
|
|
E-Folder - How Some Venture Capitalists Try To Rob You Blind
Probably the single best way to finance buying a business is with investors.
Not banks.
Not famil
Not banks.
Not famil
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
y.
And definitely not loans from other non-banking organizations.
However, I recently heard somet
And definitely not loans from other non-banking organizations.
However, I recently heard somet
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ing that made me think twice about exactly what kind of investor financing is best.
You see, while
You see, while
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
it's true investor financing means you don't have to pay any interest (after all, they are investin
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
g money, not loaning it), not all investors are made of the same stuff.
In this case, I learned ab
In this case, I learned ab
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ut a dirty little trick many of the more "unscrupulous" venture capital firms will play on people.
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
And that is to sort of "string you along" when you ask for money.
In other words, they will keep s
In other words, they will keep s
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
aying you will get the money you need next month or next week or whenever.
But in reality, they ha
But in reality, they ha
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
e no intention of giving you anything until the last possible minute.
Why?
Because, as any con ma
Why?
Because, as any con ma
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
knows, when it comes to giving someone money, the longer they wait to give it to you...the more de
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
perate you'll be.
And the more desperate you are, the more they can ask from you in return.
In th
And the more desperate you are, the more they can ask from you in return.
In th
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
e case of venture capital firms, it will usually be getting more stock (and thus, control of your c
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
mpany) for their money.
It’s a terrible thing for them to do. But many venture capital companies
It’s a terrible thing for them to do. But many venture capital companies
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
o it and so, you should be careful if you use one.
But really, this shouldn't be a problem for 99%
But really, this shouldn't be a problem for 99%
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
of people who buy a business.
Because if you are buying a smaller business, venture capitalists g
Because if you are buying a smaller business, venture capitalists g
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
nerally won't bother with you anyway (that's where "angel investors" come in to play).
And if you
And if you
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
re buying a larger business (worth, say, $5, $10, $15 million or more) there are plenty of private
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
investors -- with more money than they can spend -- who will give you whatever financing you need i
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
what you are doing makes sense to them.
Anyway, keep this article in mind when thinking about how
Anyway, keep this article in mind when thinking about how
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
to finance a business you want to buy, especially if you don't want to use a bank or other creditor
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-folder.org.ua/article/46596/e-folder-How-Some-Venture-Capitalists-Try-To-Rob-You-Blind.html">How Some Venture Capitalists Try To Rob You Blind</a>
BB link (for phorums):
[url=http://www.e-folder.org.ua/article/46596/e-folder-How-Some-Venture-Capitalists-Try-To-Rob-You-Blind.html]How Some Venture Capitalists Try To Rob You Blind[/url]
Related Articles:
A Quick Reference to Nursing Schools
How to Make Money as a Reflexologist
Get a Life and Maximize Your Marketing
Bookmark it:
|